Table of Contents
Pathology Research International
Volume 2017, Article ID 4302459, 8 pages
https://doi.org/10.1155/2017/4302459
Research Article

Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya

1Department of Medical Laboratory Science, School of Medicine and Health Sciences, Kenya Methodist University, P.O. Box 45240-00100, Nairobi, Kenya
2Department of Public Health, Jomo Kenyatta University of Agriculture and Technology (JKUAT), P.O. Box 62000-00200, Nairobi, Kenya
3Department of Animal Sciences, Jomo Kenyatta University of Agriculture and Technology (JKUAT), P.O. Box 62000-00200, Nairobi, Kenya
4Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology (JKUAT), P.O. Box 62000-00200, Nairobi, Kenya
5Department of Animal Health & Production, Mount Kenya University, P.O. Box 342-01000, Thika 342-01000, Kenya

Correspondence should be addressed to John Maina Kagira; moc.liamg@arigakj

Received 25 January 2017; Accepted 19 April 2017; Published 24 May 2017

Academic Editor: Shahid Pervez

Copyright © 2017 John Mokua Mose et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. W. Esch, “Toxoplasmosis of animals and humans, second edition,” Journal of Parasitology, vol. 96, no. 5, pp. 940–940, 2010. View at Google Scholar
  2. D. H. Joynson and T. G. Wreghitt, “Toxoplasmosis: a comprehensive clinical guide,” Clinical Infectious Diseases, vol. 34, no. 12, pp. 1664-1665, 2002. View at Google Scholar
  3. T. R. Bowry, M. E. Camargo, and M. Kinyanjui, “Sero-epidemiology of Toxoplasma gondii infection in young children in Nairobi, Kenya,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 80, no. 3, pp. 439–441, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Liesenfeld, “Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?” Journal of Infectious Diseases, vol. 185, supplement 1, pp. S96–S101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Barragan and L. David Sibley, “Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence,” Journal of Experimental Medicine, vol. 195, no. 12, pp. 1625–1633, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Hunter, D. Spiegelman, H.-O. Adami et al., “Cohort studies of fat intake and the risk of breast cancer—a pooled analysis,” New England Journal of Medicine, vol. 334, no. 6, pp. 356–361, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Djurkovic-Djakovic and V. Milenkovic, “Model of drug-induced reactivation of Toxoplasma gondii,” Acta Protozool, vol. 40, pp. 99–106, 2001. View at Google Scholar
  8. K.-N. Kang, I.-U. Choi, D.-W. Shin, and Y.-H. Lee, “Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamathasone,” The Korean journal of parasitology, vol. 44, no. 3, pp. 209–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Suzuki and J. S. Remington, “Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment,” Research in Immunology, vol. 144, no. 1, pp. 66–79, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. L. L. Johnson, “SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections,” Infection and Immunity, vol. 60, no. 9, pp. 3719–3724, 1992. View at Google Scholar
  11. F. Beermann, S. J. Orlow, and M. L. Lamoreux, “The Tyr (albino) locus of the laboratory mouse,” Mammalian Genome, vol. 15, no. 10, pp. 749–758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Subauste, “Animal models for Toxoplasma gondii infection,” in Current Protocols in Immunology, chapter 19, unit 19.3.1-23, 2012. View at Google Scholar
  13. A. Ole, “OIE Manual of diagnostic tests and vaccines for terrestrial animals,” Toxoplasmosis, vol. 1, article 1286, no. 6, 2008. View at Google Scholar
  14. S. K. Thiong’o, J. M. Ichagichu, M. Ngotho et al., “Use of the nested polymerase chain reaction for detection of Toxoplasma gondii in slaughterhouse workers in Thika District, Kenya,” South African Medical Journal, vol. 106, no. 4, pp. 417–419, 2016. View at Publisher · View at Google Scholar
  15. J. M. Mose, J. M. Kagira, S. M. Karanja et al., “Detection of natural Toxoplasma gondii infection in chicken in thika region of kenya using nested polymerase chain reaction,” BioMed Research International, vol. 2016, Article ID 7589278, 5 pages, 2016. View at Publisher · View at Google Scholar
  16. J. D. Kawedia, L. Janke, A. J. Funk et al., “Substrain-specific differences in survival and osteonecrosis incidence in a mouse model,” Comparative Medicine, vol. 62, no. 6, pp. 466–471, 2012. View at Google Scholar
  17. S. Nicoll, S. Wright, S. W. Maley, S. Burns, and D. Buxton, “A mouse model of recrudescence of Toxoplasma gondii infection,” Journal of Medical Microbiology, vol. 46, no. 3, pp. 263–266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. L. M. Weiss and K. Kim, “The development and biology of bradyzoites of Toxoplasma gondii,” Frontiers in Bioscience: A Journal and Virtual Library, vol. 5, pp. D391–D405, 2000. View at Google Scholar
  19. S. Parasuraman, R. Raveendran, and R. Kesavan, “Blood sample collection in small laboratory animals,” Journal of Pharmacology and Pharmacotherapeutics, vol. 1, no. 2, pp. 87–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Tanaka, M. Nishimura, F. Ihara, J. Yamagishi, Y. Suzuki, and Y. Nishikawa, “Transcriptome analysis of mouse brain infected with Toxoplasma gondii,” Infection and Immunity, vol. 81, no. 10, pp. 3609–3619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. S. Yap and A. Sher, “Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function,” Immunobiology, vol. 201, no. 2, pp. 240–247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Silva, A. O. Kamphorst, E. A. Hayashi et al., “Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response,” Immunology, vol. 130, no. 3, pp. 447–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Falangola, B. S. Reichler, and C. K. Petito, “Histopathology of cerebral toxoplasmosis in human immunodeficiency virus infection: a comparison between patients with early-onset and late-onset acquired immunodeficiency syndrome,” Human Pathology, vol. 25, no. 10, pp. 1091–1097, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Strittmatter, W. Lang, O. D. Wiestler, and P. Kleihues, “The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases,” Acta Neuropathologica, vol. 83, no. 5, pp. 475–481, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Chimelli, “A Morphological approach to the diagnosis of protozoal infections of the central nervous system,” Pathology Research International, vol. 2011, Article ID 290853, 15 pages, 2011. View at Publisher · View at Google Scholar
  26. I. Dellacasa-Lindberg, N. Hitziger, and A. Barragan, “Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging,” Microbes and Infection, vol. 9, no. 11, pp. 1291–1298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Antopol, “Anatomic changes produced in mice treated with excessive doses of cortisone,” Proceedings of the Society for Experimental Biology and Medicine, vol. 73, no. 2, pp. 262–265, 1950. View at Publisher · View at Google Scholar · View at Scopus
  28. I. H. Grant, J. W. M. Gold, M. Rosenblum, D. Niedzwiecki, and D. Armstrong, “Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS,” AIDS, vol. 4, no. 6, pp. 519–521, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. A. W. Ferreira and M. E. Camargo, “Toxoplasmosis and the laboratory: diagnosis and a constant striving for improvement,” Journal of the Institute of Tropical Medicine of São Paulo, vol. 44, no. 3, pp. 119-120, 1990. View at Google Scholar
  30. J. Singh, C. Graniello, Y. Ni et al., “Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection,” Microbes and Infection, vol. 12, no. 14-15, pp. 1252–1257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. E. F. Torrey and R. H. Yolken, “Toxoplasma gondii and Schizophrenia,” Emerging Infectious Diseases, vol. 9, no. 11, pp. 1375–1380, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. E. W. Stommel, R. Seguin, V. M. Thadani et al., “Cryptogenic epilepsy: an infectious etiology?” Epilepsia, vol. 42, no. 3, pp. 436–438, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. F. M. Leweke, C. W. Gerth, D. Koethe et al., “Antibodies to infectious agents in individuals with recent onset schizophrenia,” European Archives of Psychiatry and Clinical Neuroscience, vol. 254, no. 1, pp. 4–8, 2004. View at Publisher · View at Google Scholar · View at Scopus